SCHEMBL7268287

SCHEMBL7268287

OCCOCCOCCNCCOCCNC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.46
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 3/20 0.43
MIF P14174 1/20 0.43
KCNN4 O15554 1/20 0.41
KCNH3 Q9ULD8 2/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 3/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
DUT P33316 1/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
CD274 Q9NZQ7 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25601858 0.95 KIF11 (0.50) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL17980744 0.94 KIF11 (0.52) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7263691 0.92 KIF11 (0.53) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7262278 0.84 KIF11 (0.59) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7269694 0.84 KIF11 (0.59) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7263696 0.84 KIF11 (0.42) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7268298 0.79 KIF11 (0.65) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL7263720 0.79 KIF11 (0.65) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL20823126 0.79 KIF11 (0.50) KIF11ALDH1A1KDM4EMIFKCNN4
SCHEMBL28640563 0.78 KIF11 (0.49) KIF11MIFKCNN4TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030138432-A1 Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs DRUG INNOVATION & DESIGN, INC. 2003-07-24 US disclosed
EP-1255567-A1 SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES Drug Innovation & Design, Inc. (US) 2002-11-13 EP disclosed
WO-2001036003-A2 SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES DRUG INNOVATION & DESIGN, INC. (US) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030138432-A1 Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs PAICS, ABCB1, ABCG2 KIF11 3005/4885ALDH1A1 589/4885KDM4E 1551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.